BioXcel Therapeutics director Susan E. Atkins files initial beneficial ownership statement
BTAI•Initial Form 3 filing
BioXcel Therapeutics director Susan E. Atkins filed an initial Form 3 insider ownership statement dated Aug. 12, 2026.
Related News
Conrad Industries Q2 profit falls on lower production volume
CNRD•
Brazil's Petrobras finds hydrocarbons in Foz do Amazonas basin
PBR•
Nasdaq trade halt continues YYAI.O halt news pending at 08:30 PM
YYAI•
Nasdaq trade halt continues <TALK.O> trading halted; for information requested by Nasdaq at 08:04 pm
TALK•
Nasdaq trade halt continues <PFSA.O> halt news pending at 08:04 PM
PFSA•